Laminate Medical brings in $12m for dialysis vascular support device

Israeli medtech start-up Laminate Medical Technologies said today that it raised $12 million in a new round of financing slated to support its VasQ vascular support device. The company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The VasQ regulates flow by constraining and shaping optimal geometrical parameters of the fistula, the company said, and reinforces and shields the vulnerable perianastomotic vein against high pressure, wall tension and flow levels. The round was joined by Asahi Kasei (TYO:3407) and Tal Capital, as well as a number of private investors, Laminate Medical Tech said. “We are so happy to be a part of the company’s journey. I believe VasQ has a high potential to become the standard of care for vascular access surgery,” Asahi Kasei Medical prez Takeshi Himeno said in a prepared statement. The company said that it recently launched U.S.-based clinical trials of the VasQ system as it seeks FDA approval of the device. The system already has CE Mark approval in the European Union. “After the success of treatments in Europe, including application of the device in hundreds of patients in Germany and other European countries, we are now preparing to enter the American market. We have completed the infrastructure for this, and are working in cooperation with leading hospitals across the USA to carry out the necessary clinical trials for FDA ap...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Dialysis Featured Vascular Laminate Medical Technologies Source Type: news